The Ottobock share has completed its first two days of trading. The strong political headwind on Friday also only slightly dampened investor sentiment.
• Ottobock has a strong start to the stock market with prices well above the issue price
• Political tensions caused by Trump are weighing on markets, but shares are holding up better than the market
• High demand and oversubscription show trust in the medical technology company
The medical technology giant Ottobock has conquered the Frankfurt stock exchange. With an issue price of 66 euros, the IPO is considered a success – especially since the mark remains skipped even after turbulent Friday trading.
Brilliant start to trading exceeds all expectations
Ottobock shares had an impressive start to the stock market on Thursday. The paper from the world’s leading manufacturer of prostheses and orthopedic medical technology opened for trading on October 9, 2025 at 72 euros – well above the issue price of 66 euros, which was already at the upper end of the price range. Over the course of the day, the share even reached a high of 73 euros before closing the first day of trading at around 69.60 euros. This corresponds to an increase of around 5.5% compared to the issue price.
Trump crashes success
The fact that the second day of trading did not end on a green note was due to the weak overall situation on the market. After Donald Trump made renewed tariff threats against China, the markets went into reverse and the Ottobock share was also unable to stay in the profit zone and ended Friday trading on XETRA with a discount of 0.72 percent at 68.50 euros. However, the share held up better than the broader market and also closed well above the issue price.
Strong demand – but also critical voices
The high demand for Ottobock shares reflects the great trust investors have in the medical technology specialist. The issue was significantly oversubscribed in advance, with bids below the issue price having little chance of being allocated, as reports show. A total of around 13.8 million shares were placed, of which around 1.5 to 1.6 million came from a capital increase. The rest came from the Näder family, which remains the majority shareholder with over 80%. The free float is therefore around 19%.
Nevertheless, the ambitious assessment also raises questions – particularly with regard to the financial indicators. In 2024, the company achieved sales of 1.6 billion euros with an EBIT of 143.3 million euros. The after-tax result was 27.9 million euros, adjusted at around 96.8 million euros. Extrapolated, this results in earnings per share of around 0.88 euros for the full year 2025.
It remains to be seen whether the Ottobock share can sustainably hold its own in the current market environment. Investors are likely to continue to closely monitor the high level of debt, which Jochen Stanzl from broker CMC Markets sees as a possible reason for the owner family to sell further blocks of shares.
Editorial team finanzen.net
Selected leverage products on Ottobock
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Ottobock
The leverage must be between 2 and 20
Advertising
Image sources: Roman Babakin / Shutterstock.com, Wirestock Creators / Shutterstock.com